|
PGAM1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.736300E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.400700E-03 |
| Normal-vs-Stage2 |
3.343200E-01 |
| Normal-vs-Stage3 |
5.613900E-02 |
| Normal-vs-Stage4 |
3.309600E-02 |
| Stage1-vs-Stage2 |
2.899800E-01 |
| Stage1-vs-Stage3 |
5.163200E-01 |
| Stage1-vs-Stage4 |
8.983400E-01 |
| Stage2-vs-Stage3 |
6.397400E-01 |
| Stage2-vs-Stage4 |
3.957400E-01 |
| Stage3-vs-Stage4 |
6.029200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.380900E-03 |
| Normal-vs-AfricanAmerican |
4.372000E-01 |
| Normal-vs-Asian |
4.040000E-03 |
| Caucasian-vs-AfricanAmerican |
2.018600E-01 |
| Caucasian-vs-Asian |
4.333600E-01 |
| AfricanAmerican-vs-Asian |
1.075050E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.615900E-03 |
| Normal-vs-Female |
8.023200E-03 |
| Male-vs-Female |
4.667200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.180500E-03 |
| Normal-vs-Age(41-60Yrs) |
2.842100E-03 |
| Normal-vs-Age(61-80Yrs) |
2.022200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.077800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.533400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.242400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.315000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.967000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.191000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.801200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.948000E-01 |
| Classical-VS-Follicular |
7.839600E-01 |
| Classical-VS-Other |
1.343150E-01 |
| Classical-VS-Normal |
2.978100E-03 |
| Tall-VS-Follicular |
2.765200E-01 |
| Tall-VS-Other |
1.458960E-01 |
| Tall-VS-Normal |
7.243800E-01 |
| Follicular-VS-Other |
3.334600E-01 |
| Follicular-VS-Normal |
2.490200E-02 |
| Other-VS-Normal |
8.693800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.179900E-03 |
| Normal-vs-N1 |
3.988399999999E-05 |
| N0-vs-N1 |
1.067650E-02 |
|
|
